- A Retinal Expert Recognized Globally in both the Medical Community and Biotech/Pharma Ophthalmic Industry - NEW YORK --(BUSINESS WIRE)--Mar. 23, 2020-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and

NEW YORK --(BUSINESS WIRE)-- IVERIC bio, Inc. (Nasdaq: ISEE) today announced that due to the threat of the coronavirus (COVID-19) global pandemic, the Company has decided to delay the initiation of enrollment of patients in the second pivotal clinical trial for Zimura ® (avacincaptad pegol), a

NEW YORK --(BUSINESS WIRE)-- IVERIC bio, Inc. (Nasdaq: ISEE) today reported that on March 2, 2020 , the Company granted a newly hired, non-executive employee a non-statutory stock option to purchase 18,500 shares of the Company’s common stock. In addition, on March 2, 2020 , the Company granted